US Patent Issued to ALACRITY PATIENT SERVICES on June 3 for "Method and apparatus for monitoring development of medication induced side effects" (California Inventor)

ALEXANDRIA, Va., June 4 -- United States Patent no. 12,318,228, issued on June 3, was assigned to ALACRITY PATIENT SERVICES INC. (San Francisco).

"Method and apparatus for monitoring development of medication induced side effects" was invented by David Berz (Los Angeles).

According to the abstract* released by the U.S. Patent & Trademark Office: "Systems and methods for home monitoring and detection of febrile neutropenia in a patient are provided. The system includes a photoplethysmographic sensor for sensing photoplethysmographic signals of the patient, and one or more blood borne parameter sensors for sensing parameters in the patient's blood. A febrile neutropenia monitoring application receives information sensed by the photoplethysm...